| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |